NIH awards OHSU scientists, collaborators $8.4 million to develop a cure for HIV
Only a handful of people in history have been cured of the virus; three have agreed to kick off landmark research project led by OHSU.
Research
More Research Stories
- Latest Stories
‘Exception from informed consent’ study will assess emergency treatment for prolonged seizures
October 15, 2015
Oregon Health & Science University is one of 40 centers across the country participating in an emergency medicine study that aims to save and improve the lives of adults and children 2 years and older whose life-threatening seizures are resistant to standard treatment.
Immunovia, OHSU collaborating on early detection test for pancreatic cancer
October 04, 2015
Immunovia AB and the Knight Cancer Institute at Oregon Health & Science University (OHSU) formed a collaboration to confirm, validate and commercialize a blood test for the early diagnosis of pancreatic cancer. The test called IMMray™ PanCan-d analyses a patient’s immune system for early signs of disease. The collaboration will also enable researchers to explore biomarkers for a number of other cancer types.
Research: Face-to-face socializing more powerful than phone calls, emails in guarding against depression in older adults
October 04, 2015
In a slight knock on digital and telephone communications, a new study points to the unsurpassed mental health benefits of regular face-to-face social interactions among older adults.
Collaborative Cancer Cloud launches
September 03, 2015
The following is an excerpt of the Aug. 19, 2015, Directline from the President’s Office. A little more than two years ago, OHSU and Intel joined forces to combine next-generation computing platforms with our unique capabilities in biomedical ...
Pediatric training essential to improving out-of-hospital emergency care for children
August 18, 2015
A national survey of more than 750 emergency medical services providers conducted by researchers at Oregon Health & Science University identified airway management skills, personal anxiety and limited pediatric care proficiency among key factors that may contribute to pediatric safety events for children in out-of-hospital emergent care situations.
Study: Lifesaving antibiotics increase risk of lifelong hearing loss in patients with deadly bacterial infections
July 29, 2015
Seeking to stem the tide of permanent hearing loss from the use of lifesaving antibiotics, researchers at Oregon Health & Science University have found that patients stricken with dangerous bacterial infections are at greater risk of hearing loss than previously recognized.
Breast cancer survivors who experience pain during intercourse may benefit from lidocaine treatment
July 27, 2015
Scientists at Oregon Health & Science University report that breast cancer survivors who experience pain during sexual intercourse, a common side effect of breast cancer treatment, may achieve comfort when liquid lidocaine is applied strategically to prevent pain.
Grant applicants sought for OHSU program to reduce cancer’s impact on Oregonians
July 20, 2015
The Knight Cancer Institute at Oregon Health & Science University (OHSU) is seeking grant applicants statewide to receive funding through a program dedicated to supporting community-specific projects that meet cancer-related needs.
Magnetic pulses to the brain deliver long-lasting relief for tinnitus patients: VA and OHSU study
July 16, 2015
In the largest U.S. clinical trial of its kind funded by the Veterans Affairs (VA) Rehabilitation Research and Development Service, researchers at the VA Portland Medical Center and Oregon Health & Science University found that transcranial magnetic stimulation significantly improved tinnitus symptoms for more than half of study participants.
OHSU scientists unlock first critical step toward gene therapy treatment for patients with mitochondrial disease
July 15, 2015
A study led by Shoukhrat Mitalipov, Ph.D., and Hong Ma, M.D., Ph.D., at the Center for Embryonic Cell and Gene Therapy at Oregon Health & Science University and the Oregon National Primate Research Center has revealed the first critical step in developing novel gene and stem cell therapy treatments for patients with mitochondrial disease.